Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | DNA topoisomerase 2-alpha/2-beta | ||
Ligand | BDBM50286494 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_208605 (CHEMBL812282) | ||
EC50 | 1700±n/a nM | ||
Citation | Wentland, MP; Aldous, SC; Gruett, MD; Perni, RB; Powles, RG; Danz, DW; Klingbeil, KM; Peverly, A; Robinson, RG; Corbett, TH; Rake, JB; Coughlin, SA The antitumor activity of novel pyrazoloquinoline derivatives Bioorg Med Chem Lett5:405-410 (1995) Article | ||
More Info.: | Get all data from this article, Assay Method | ||
DNA topoisomerase 2-alpha/2-beta | |||
Name: | DNA topoisomerase 2-alpha/2-beta | ||
Synonyms: | DNA topoisomerase II | ||
Type: | n/a | ||
Mol. Mass.: | n/a | ||
Description: | ASSAY_ID of ChEMBL is 1821483 | ||
Components: | This complex has 2 components. | ||
Component 1 | |||
Name: | DNA topoisomerase 2-alpha | ||
Synonyms: | DNA topoisomerase 2-alpha | DNA topoisomerase II | DNA topoisomerase II (Topo II) | DNA topoisomerase II alpha | DNA topoisomerase II, alpha isozyme | TOP2 | TOP2A | TOP2A_HUMAN | Topoisomerase I/II | Topoisomerase II alpha (HuTopoIIα) | ||
Type: | Protein | ||
Mol. Mass.: | 174415.30 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P11388 | ||
Residue: | 1531 | ||
Sequence: |
| ||
Component 2 | |||
Name: | DNA topoisomerase 2-beta | ||
Synonyms: | DNA topoisomerase II | DNA topoisomerase II beta | TOP2B | TOP2B_HUMAN | ||
Type: | PROTEIN | ||
Mol. Mass.: | 183284.13 | ||
Organism: | Homo sapiens (Human) | ||
Description: | ChEMBL_51583 | ||
Residue: | 1626 | ||
Sequence: |
| ||
BDBM50286494 | |||
n/a | |||
Name | BDBM50286494 | ||
Synonyms: | 5-Cyclopropyl-2-(4-dimethylamino-cyclohexyl)-7-(2,6-dimethyl-pyridin-4-yl)-6,8-difluoro-2,5-dihydro-pyrazolo[4,3-c]quinolin-3-one | CHEMBL336549 | ||
Type | Small organic molecule | ||
Emp. Form. | C28H31F2N5O | ||
Mol. Mass. | 491.5754 | ||
SMILES | CN(C)[C@H]1CC[C@H](CC1)n1nc2c(cn(C3CC3)c3c(F)c(c(F)cc23)-c2cc(C)nc(C)c2)c1=O |wU:6.9,3.2,(17.41,1.96,;15.87,1.96,;15.1,3.29,;15.1,.63,;15.87,-.71,;15.1,-2.03,;13.58,-2.03,;12.79,-.71,;13.56,.63,;12.81,-3.37,;11.29,-3.52,;10.97,-5.04,;12.3,-5.81,;12.3,-7.35,;10.97,-8.12,;10.97,-9.66,;10.2,-11,;11.74,-10.99,;9.64,-7.35,;8.31,-8.12,;8.31,-9.66,;6.96,-7.35,;6.96,-5.81,;5.62,-5.04,;8.31,-5.04,;9.64,-5.81,;5.63,-8.12,;4.29,-7.35,;2.96,-8.12,;1.61,-7.33,;2.96,-9.66,;4.3,-10.43,;4.32,-11.97,;5.63,-9.66,;13.45,-4.76,;14.96,-5.07,)| | ||
Structure |